Donghui Li

18.8k total citations · 2 hit papers
174 papers, 9.4k citations indexed

About

Donghui Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Donghui Li has authored 174 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 67 papers in Oncology and 45 papers in Cancer Research. Recurrent topics in Donghui Li's work include Pancreatic and Hepatic Oncology Research (49 papers), Carcinogens and Genotoxicity Assessment (23 papers) and Liver Disease Diagnosis and Treatment (21 papers). Donghui Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (49 papers), Carcinogens and Genotoxicity Assessment (23 papers) and Liver Disease Diagnosis and Treatment (21 papers). Donghui Li collaborates with scholars based in United States, China and Australia. Donghui Li's co-authors include James L. Abbruzzese, Robert A. Wolff, Keping Xie, Manal M. Hassan, Kurt Randerath, Ping Chang, Xiaoqun Dong, Douglas B. Evans, Subrata Sen and Li Jiao and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

Donghui Li

169 papers receiving 9.2k citations

Hit Papers

Pancreatic cancer 2004 2026 2011 2018 2004 2017 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donghui Li United States 47 4.5k 4.1k 2.5k 1.6k 1.6k 174 9.4k
Brian M. Wolpin United States 46 3.7k 0.8× 2.6k 0.6× 1.9k 0.8× 1.2k 0.7× 1.1k 0.7× 180 7.3k
O. Joe Hines United States 56 4.3k 1.0× 2.7k 0.7× 1.7k 0.7× 2.7k 1.6× 955 0.6× 215 8.6k
Zhaohui Zou United States 14 4.2k 0.9× 4.1k 1.0× 2.5k 1.0× 1.8k 1.1× 1.1k 0.7× 26 11.2k
Masato Sakon Japan 54 2.8k 0.6× 3.4k 0.8× 1.6k 0.7× 2.4k 1.5× 1.6k 1.0× 383 9.9k
Lola Rahib United States 17 5.0k 1.1× 2.1k 0.5× 2.2k 0.9× 1.4k 0.8× 922 0.6× 36 7.0k
Selwyn M. Vickers United States 59 4.6k 1.0× 3.1k 0.7× 1.1k 0.4× 3.2k 2.0× 1.1k 0.7× 244 9.7k
Boon Cher Goh Singapore 53 3.1k 0.7× 4.2k 1.0× 1.7k 0.7× 585 0.4× 686 0.4× 227 8.8k
Scott D. Patterson United States 47 3.0k 0.7× 4.9k 1.2× 1.1k 0.4× 946 0.6× 1.5k 1.0× 219 11.0k
Brian I. Carr United States 56 3.1k 0.7× 3.4k 0.8× 1.7k 0.7× 3.3k 2.0× 3.3k 2.1× 375 13.1k
John D. Schuetz United States 74 10.9k 2.4× 6.6k 1.6× 1.2k 0.5× 2.1k 1.3× 1.3k 0.8× 196 19.4k

Countries citing papers authored by Donghui Li

Since Specialization
Citations

This map shows the geographic impact of Donghui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghui Li more than expected).

Fields of papers citing papers by Donghui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghui Li. The network helps show where Donghui Li may publish in the future.

Co-authorship network of co-authors of Donghui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Donghui Li. A scholar is included among the top collaborators of Donghui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghui Li. Donghui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Tianzhong, et al.. (2024). Identification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smoking. JCO Precision Oncology. 8(8). e2300355–e2300355. 1 indexed citations
2.
Li, Donghui. (2024). Innovating Culinary Health: The Nutritional Potential of Chinese-Western Fusion Cuisine. 7(2). p61–p61. 1 indexed citations
3.
Hatia, Rikita, Ernest T. Hawk, Ahmed Shalaby, et al.. (2023). Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1338–1347. 2 indexed citations
4.
Hu, Wei, et al.. (2023). Tetrahydrocurcumin (THC) enhanced the clearance of Cryptococcus deneoformans during infection in vivo. Antonie van Leeuwenhoek. 116(6). 565–576. 2 indexed citations
5.
Liu, Yi, Yasunori Deguchi, Daoyan Wei, et al.. (2022). Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nature Communications. 13(1). 2665–2665. 45 indexed citations
6.
Lei, Guanglin, Hao Yang, Fang Sun, et al.. (2022). Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma. Human Gene Therapy. 33(5-6). 309–317. 4 indexed citations
7.
Zou, Xiaojing, Minghao Fang, Shusheng Li, et al.. (2020). Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection. Clinical Gastroenterology and Hepatology. 19(3). 597–603. 68 indexed citations
8.
Wang, Yujia, et al.. (2018). Synthesis and Biological Evaluation of Substituted Indole and Its Analogs as Influenza A Virus Inhibitors. Chemistry & Biodiversity. 16(2). e1800577–e1800577. 7 indexed citations
9.
Li, Ming, Laszlo Radvanyi, Bingnan Yin, et al.. (2017). Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Clinical Cancer Research. 23(19). 5892–5911. 98 indexed citations
10.
Luo, Zhaofan, Yanan Li, Mingxin Zuo, et al.. (2016). Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial‐mesenchymal transition (EMT) markers. Molecular Carcinogenesis. 56(5). 1438–1448. 33 indexed citations
12.
McWilliams, Robert R., Patrick Maisonneuve, William R. Bamlet, et al.. (2015). Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma. Pancreas. 45(2). 311–316. 93 indexed citations
13.
Javle, Milind, Yanan Li, Dongfeng Tan, et al.. (2014). Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer. PLoS ONE. 9(1). e85942–e85942. 94 indexed citations
15.
Sadeghi, Navid, James L. Abbruzzese, Sai‐Ching J. Yeung, Manal M. Hassan, & Donghui Li. (2012). Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer. Clinical Cancer Research. 18(10). 2905–2912. 245 indexed citations
16.
Hassan, Manal M., Alexandria T. Phan, Donghui Li, et al.. (2008). Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study. Cancer Epidemiology Biomarkers & Prevention. 17(4). 959–965. 38 indexed citations
17.
Chang, Ping, Manal M. Hassan, James L. Abbruzzese, et al.. (2004). Background and H2O2-induced micronuclei in peripheral blood lymphocytes as a risk factor for pancreatic cancer. Cancer Research. 64. 454–454. 3 indexed citations
18.
Soliman, Amr S., Suryanarayana V. Vulimiri, Heather E. Kleiner, et al.. (2004). High levels of oxidative DNA damage in lymphocyte DNA of premenopausal breast cancer patients from Egypt. International Journal of Environmental Health Research. 14(2). 121–134. 29 indexed citations
19.
Yu, Fu‐Li, et al.. (1998). Evidence for the DNA binding and adduct formation of estrone and 17β-estradiol after dimethyldioxirane activation. Chemico-Biological Interactions. 110(3). 173–187. 9 indexed citations
20.
Moorthy, Bhagavatula, Shawn Chen, Donghui Li, & Kurt Randerath. (1993). 3-Methylcholanthrene-inducible liver cytochrome(s) P450 in female Sprague-Dawley rats: possible link between P450 turnover and formation of DNA adducts and I-compounds. Carcinogenesis. 14(5). 879–886. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026